Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One-Month Dosing of Lemborexant for Treatment of Moderate OSA Patients With Low Arousal Threshold, a Randomized, Double-blind, Crossover, Placebo-Controlled Trial

NCT07683442 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT07683442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07683442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One-Month Dosing of Lemborexant for Treatment of Moderate OSA Patients With Low Arousal Threshold, a Randomized, Double-blind, Crossover, Placebo-Controlled Trial
Lead sponsor
Chulalongkorn University
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
June 30, 2028
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osa - obstructive sleep apnea